NOVEMBER 2024LIFE SCIENCES REVIEW4CONTENTSLAST WORDIN MY OPINION08Establishing a Biotech company in Europe: A mission impossible?Rüdiger Schulze, Vice President and General Manager, DACH, Ultragenyx30A proposal for a new strategy in oncology clinical developmentStefano Ferrara, Director, Clinical Science, BeiGeneSWISS PRECISION TO DRIVE GLOBAL IMMUNOASSAY INNOVATION EXCELLENCESonia Accossato, Senior Scientist and Business DevelopmentSWISS BIOTECH TOP 10COMPANIES 202412 COVER STORY
< Page 3 | Page 5 >